Answers are grounded in this paper and cite their sources.
Assessing oncological disease progression is a major part of radiologists’ work. Today, such assessment is usually done by either eyeballing or few 2D diameter measurements.
No takes yet. Share an insight, caveat, or question.
Barash et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: